Notably, according to LOGpc, a web-based tool providing gene expressions and survival information, high expression of RPS5 is significantly associated with poorer outcome in colorectal cancer (hazard ratio [HR], 2.9453; 95% CI, 1.1864 to 7.3117; P = 0.0199; Fig. 2H) and lung cancer (HR, 2.1409; 95% CI, 1.5805 to 2.9001; P < 0.0001; Fig. 2I) (21), suggesting that RPS5 plays an oncogenic role. The gene discussed is RPS5; the disease is lung carcinoma.